A collaborative project to convey the guarantee of cell therapy to patients by using a fatal type of brain most cancers has shown dramatic success amongst the first patients to acquire the novel treatment method.Slow patient enrollment or failing to enroll the necessary variety of patients can be a disruptor of clinical trial timelines. To meet the